In the last 12 months, insiders at Edgewise Therapeutics, Inc. ($EWTX) filed 216 transactions with the SEC: 7 open-market purchases totaling $30,199,394 and 57 sales totaling $26,387,407. Net insider sentiment: net buying.
Edgewise Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Thompson Peter A. (Director) — 3 transactions totaling $14,999,995
- ORBIMED ADVISORS LLC (Director) — 3 transactions totaling $14,999,995
- Russell Alan J (Chief Scientific Officer) — 35 transactions totaling $8,862,618
- Carruthers R Michael (Chief Financial Officer) — 25 transactions totaling $5,484,084
- Donovan Joanne M. (CMO) — 25 transactions totaling $3,735,702
View all SEC Filings for Edgewise Therapeutics, Inc. (EWTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Fox Jonathan C | Not found | A | Common Stock | 339 | $0.00 | 24,514.0000 | 102,930,744 | 1.40% | 0.00% |
| April 1, 2026 | Donovan Joanne M. | CMO | M | Stock Option (Right to Buy) | 28662 | $0.00 | 125,000.0000 | 102,930,744 | 18.65% | 0.03% |
| April 1, 2026 | Donovan Joanne M. | CMO | M | Common Stock | 28662 | $7.08 | 38,259.0000 | 102,930,744 | 298.66% | 0.03% |
| April 1, 2026 | Donovan Joanne M. | CMO | S | Common Stock | 28662 | $32.31 | 9,597.0000 | 102,930,744 | 74.92% | 0.03% |
| March 31, 2026 | Donovan Joanne M. | CMO | S | Common Stock | 21338 | $32.12 | 9,597.0000 | 102,930,744 | 68.98% | 0.02% |
| March 31, 2026 | Donovan Joanne M. | CMO | M | Stock Option (Right to Buy) | 21338 | $0.00 | 153,662.0000 | 102,930,744 | 12.19% | 0.02% |
| March 31, 2026 | Donovan Joanne M. | CMO | M | Common Stock | 21338 | $7.08 | 30,935.0000 | 102,930,744 | 222.34% | 0.02% |
| March 27, 2026 | Donovan Joanne M. | CMO | S | Common Stock | 6735 | $30.98 | 9,597.0000 | 102,930,744 | 41.24% | 0.01% |
| March 27, 2026 | Donovan Joanne M. | CMO | S | Common Stock | 9623 | $30.98 | 16,332.0000 | 102,930,744 | 37.08% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | S | Common Stock | 13690 | $29.44 | 121,601.0000 | 102,930,744 | 10.12% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Common Stock | 66477 | $1.93 | 127,686.0000 | 102,930,744 | 108.61% | 0.06% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Common Stock | 10463 | $1.93 | 61,209.0000 | 102,930,744 | 20.62% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Common Stock | 17236 | $0.64 | 50,746.0000 | 102,930,744 | 51.44% | 0.02% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Common Stock | 13690 | $0.39 | 33,510.0000 | 102,930,744 | 69.07% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | S | Common Stock | 17236 | $29.44 | 104,365.0000 | 102,930,744 | 14.17% | 0.02% |
| Jan. 21, 2026 | Edris Badreddin | Not found | S | Common Stock | 7605 | $29.44 | 96,760.0000 | 102,930,744 | 7.29% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | S | Common Stock | 10463 | $29.44 | 86,297.0000 | 102,930,744 | 10.81% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | S | Common Stock | 66477 | $29.44 | 19,820.0000 | 102,930,744 | 77.03% | 0.06% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Stock Option (Right to Buy) | 10463 | $0.00 | 0.0000 | 102,930,744 | 100.00% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Stock Option (Right to Buy) | 66477 | $0.00 | 0.0000 | 102,930,744 | 100.00% | 0.06% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Stock Option (Right to Buy) | 7605 | $0.00 | 0.0000 | 102,930,744 | 100.00% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Stock Option (Right to Buy) | 17236 | $0.00 | 0.0000 | 102,930,744 | 100.00% | 0.02% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Stock Option (Right to Buy) | 13690 | $0.00 | 0.0000 | 102,930,744 | 100.00% | 0.01% |
| Jan. 21, 2026 | Edris Badreddin | Not found | M | Common Stock | 7605 | $0.71 | 135,291.0000 | 102,930,744 | 5.96% | 0.01% |
| Jan. 2, 2026 | Fox Jonathan C | Not found | A | Common Stock | 473 | $0.00 | 24,175.0000 | 102,930,744 | 2.00% | 0.00% |
| Nov. 19, 2025 | Martin Christopher Nathan | Not found | A | Stock Options (Right to buy) | 45150 | $0.00 | 45,150.0000 | 105,492,779 | 9999.99% | 0.04% |
| Nov. 10, 2025 | Nofi Michael | Chief Financial Officer | A | Restricted Stock Units | 43750 | $0.00 | 43,750.0000 | 105,492,779 | 9999.99% | 0.04% |
| Nov. 10, 2025 | Nofi Michael | Chief Financial Officer | A | Stock Options (Right to buy) | 262500 | $0.00 | 262,500.0000 | 105,492,779 | 9999.99% | 0.25% |
| Nov. 11, 2025 | Fox Jonathan C | Not found | P | Common Stock | 10700 | $18.64 | 23,702.0000 | 105,492,779 | 82.30% | 0.01% |
| Nov. 12, 2025 | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 1,147,365.0000 | 105,492,779 | 8.02% | 0.09% |
| Nov. 12, 2025 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 100000 | $21.12 | 23,400.0000 | 105,492,779 | 81.04% | 0.09% |
| Nov. 12, 2025 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 100000 | $0.18 | 123,400.0000 | 105,492,779 | 427.35% | 0.09% |
| Oct. 1, 2025 | Fox Jonathan C | Not found | A | Common Stock | 728 | $0.00 | 13,002.0000 | 105,492,779 | 5.93% | 0.00% |
| Aug. 26, 2025 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 100000 | $0.18 | 123,400.0000 | 104,940,493 | 427.35% | 0.10% |
| Aug. 26, 2025 | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 1,247,365.0000 | 104,940,493 | 7.42% | 0.10% |
| Aug. 26, 2025 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 100000 | $14.60 | 23,400.0000 | 104,940,493 | 81.04% | 0.10% |
| Aug. 12, 2025 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1907 | $13.39 | 23,400.0000 | 104,940,493 | 7.54% | 0.00% |
| Aug. 12, 2025 | KOCH KEVIN | President and CEO | S | Common Stock | 7972 | $13.39 | 369,399.0000 | 104,940,493 | 2.11% | 0.01% |
| Aug. 12, 2025 | KOCH KEVIN | President and CEO | M | Common Stock | 17968 | $0.00 | 377,371.0000 | 104,940,493 | 5.00% | 0.02% |
| Aug. 12, 2025 | Russell Alan J | Chief Scientific Officer | A | Stock Option (Right to Buy) | 168750 | $0.00 | 168,750.0000 | 104,940,493 | 9999.99% | 0.16% |
| Aug. 12, 2025 | Russell Alan J | Chief Scientific Officer | A | Restricted Stock Units | 28125 | $0.00 | 28,125.0000 | 104,940,493 | 9999.99% | 0.03% |
| Aug. 12, 2025 | Russell Alan J | Chief Scientific Officer | M | Restricted Stock Units | 5781 | $0.00 | 17,344.0000 | 104,940,493 | 25.00% | 0.01% |
| Aug. 12, 2025 | Donovan Joanne M. | CMO | A | Stock Option (Right to Buy) | 168750 | $0.00 | 168,750.0000 | 104,940,493 | 9999.99% | 0.16% |
| Aug. 12, 2025 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 5781 | $0.00 | 25,307.0000 | 104,940,493 | 29.61% | 0.01% |
| Aug. 12, 2025 | Blaustein Robert | Chief Development Officer | A | Restricted Stock Units | 17500 | $0.00 | 17,500.0000 | 104,940,493 | 9999.99% | 0.02% |
| Aug. 12, 2025 | Blaustein Robert | Chief Development Officer | A | Stock Options (Right to buy) | 105000 | $0.00 | 105,000.0000 | 104,940,493 | 9999.99% | 0.10% |
| Aug. 12, 2025 | MOORE JOHN R | General Counsel | M | Common Stock | 5781 | $0.00 | 12,312.0000 | 104,940,493 | 88.52% | 0.01% |
| Aug. 12, 2025 | MOORE JOHN R | General Counsel | S | Common Stock | 2098 | $13.39 | 10,214.0000 | 104,940,493 | 17.04% | 0.00% |
| Aug. 12, 2025 | MOORE JOHN R | General Counsel | M | Restricted Stock Units | 5781 | $0.00 | 17,344.0000 | 104,940,493 | 25.00% | 0.01% |
| Aug. 12, 2025 | MOORE JOHN R | General Counsel | A | Restricted Stock Units | 26875 | $0.00 | 26,875.0000 | 104,940,493 | 9999.99% | 0.03% |
| Aug. 12, 2025 | MOORE JOHN R | General Counsel | A | Stock Option (Right to Buy) | 161250 | $0.00 | 161,250.0000 | 104,940,493 | 9999.99% | 0.15% |
| Aug. 12, 2025 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 5781 | $0.00 | 26,136.0000 | 104,940,493 | 28.40% | 0.01% |
| Aug. 12, 2025 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 2491 | $13.39 | 23,645.0000 | 104,940,493 | 9.53% | 0.00% |
| Aug. 12, 2025 | Derakhshan Behrad | Chief Business Officer | M | Restricted Stock Units | 5781 | $0.00 | 17,344.0000 | 104,940,493 | 25.00% | 0.01% |
| Aug. 12, 2025 | Derakhshan Behrad | Chief Business Officer | A | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 104,940,493 | 9999.99% | 0.03% |
| Aug. 12, 2025 | Derakhshan Behrad | Chief Business Officer | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 104,940,493 | 9999.99% | 0.17% |
| Aug. 12, 2025 | Carruthers R Michael | Chief Financial Officer | M | Common Stock | 5781 | $0.00 | 87,590.0000 | 104,940,493 | 7.07% | 0.01% |
| Aug. 12, 2025 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 1428 | $13.39 | 86,162.0000 | 104,940,493 | 1.63% | 0.00% |
| Aug. 12, 2025 | Carruthers R Michael | Chief Financial Officer | M | Restricted Stock Units | 5781 | $0.00 | 17,344.0000 | 104,940,493 | 25.00% | 0.01% |
| Aug. 12, 2025 | Carruthers R Michael | Chief Financial Officer | A | Restricted Stock Units | 26875 | $0.00 | 26,875.0000 | 104,940,493 | 9999.99% | 0.03% |
| Aug. 12, 2025 | Carruthers R Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 161250 | $0.00 | 161,250.0000 | 104,940,493 | 9999.99% | 0.15% |
| Aug. 12, 2025 | Donovan Joanne M. | CMO | A | Restricted Stock Units | 28125 | $0.00 | 28,125.0000 | 104,940,493 | 9999.99% | 0.03% |
| Aug. 12, 2025 | Donovan Joanne M. | CMO | M | Restricted Stock Units | 5781 | $0.00 | 17,344.0000 | 104,940,493 | 25.00% | 0.01% |
| Aug. 12, 2025 | Donovan Joanne M. | CMO | S | Common Stock | 2862 | $13.39 | 25,361.0000 | 104,940,493 | 10.14% | 0.00% |
| Aug. 12, 2025 | Donovan Joanne M. | CMO | M | Common Stock | 5781 | $0.00 | 28,223.0000 | 104,940,493 | 25.76% | 0.01% |
| Aug. 12, 2025 | KOCH KEVIN | President and CEO | A | Stock Option (Right to Buy) | 525000 | $0.00 | 525,000.0000 | 104,940,493 | 9999.99% | 0.50% |
| Aug. 12, 2025 | KOCH KEVIN | President and CEO | A | Restricted Stock Units | 87500 | $0.00 | 87,500.0000 | 104,940,493 | 9999.99% | 0.08% |
| Aug. 12, 2025 | KOCH KEVIN | President and CEO | M | Restricted Stock Units | 17968 | $0.00 | 53,907.0000 | 104,940,493 | 25.00% | 0.02% |
| July 1, 2025 | Fox Jonathan C | Not found | A | Common Stock | 858 | $0.00 | 12,274.0000 | 104,940,493 | 7.52% | 0.00% |
| June 16, 2025 | ROOT JONATHAN D | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 95,130,053 | 9999.99% | 0.03% |
| June 16, 2025 | Thompson Peter A. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 95,130,053 | 9999.99% | 0.03% |
| June 16, 2025 | Morris Arlene | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 95,130,053 | 9999.99% | 0.03% |
| June 16, 2025 | Brege Laura | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 95,130,053 | 9999.99% | 0.03% |
| June 16, 2025 | Fox Jonathan C | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 95,130,053 | 9999.99% | 0.03% |
| June 16, 2025 | Edris Badreddin | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 95,130,053 | 9999.99% | 0.03% |
| May 1, 2025 | Carruthers R Michael | Chief Financial Officer | M | Common Stock | 5209 | $0.00 | 82,328.0000 | 95,130,053 | 6.75% | 0.01% |
| May 1, 2025 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 5209 | $0.00 | 20,072.0000 | 95,130,053 | 35.05% | 0.01% |
| May 2, 2025 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1551 | $16.45 | 18,521.0000 | 95,130,053 | 7.73% | 0.00% |
| May 1, 2025 | Russell Alan J | Chief Scientific Officer | M | Restricted Stock Units | 5209 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| May 1, 2025 | MOORE JOHN R | General Counsel | M | Common Stock | 5209 | $0.00 | 8,461.0000 | 95,130,053 | 160.18% | 0.01% |
| May 1, 2025 | MOORE JOHN R | General Counsel | M | Restricted Stock Units | 5209 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| May 1, 2025 | KOCH KEVIN | President and CEO | M | Common Stock | 10417 | $0.00 | 390,089.0000 | 95,130,053 | 2.74% | 0.01% |
| May 2, 2025 | KOCH KEVIN | President and CEO | S | Common Stock | 4276 | $16.45 | 385,813.0000 | 95,130,053 | 1.10% | 0.00% |
| May 1, 2025 | KOCH KEVIN | President and CEO | M | Restricted Stock Units | 10417 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| May 1, 2025 | Donovan Joanne M. | CMO | M | Common Stock | 10417 | $0.00 | 26,775.0000 | 95,130,053 | 63.68% | 0.01% |
| May 2, 2025 | Donovan Joanne M. | CMO | S | Common Stock | 5187 | $16.45 | 21,588.0000 | 95,130,053 | 19.37% | 0.01% |
| May 1, 2025 | Donovan Joanne M. | CMO | M | Restricted Stock Units | 10417 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| May 1, 2025 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 5209 | $0.00 | 22,046.0000 | 95,130,053 | 30.94% | 0.01% |
| May 2, 2025 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 1691 | $16.45 | 20,355.0000 | 95,130,053 | 7.67% | 0.00% |
| May 1, 2025 | Derakhshan Behrad | Chief Business Officer | M | Restricted Stock Units | 5209 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| May 2, 2025 | MOORE JOHN R | General Counsel | S | Common Stock | 1930 | $16.45 | 6,531.0000 | 95,130,053 | 22.81% | 0.00% |
| May 2, 2025 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 1314 | $16.45 | 81,014.0000 | 95,130,053 | 1.60% | 0.00% |
| May 1, 2025 | Carruthers R Michael | Chief Financial Officer | M | Restricted Stock Units | 5209 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| April 3, 2025 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 124193 | $20.13 | 443,792.0000 | 95,130,053 | 38.86% | 0.13% |
| April 3, 2025 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 372578 | $20.13 | 14,809,075.0000 | 95,130,053 | 2.58% | 0.39% |
| April 3, 2025 | Thompson Peter A. | Director | P | Common Stock | 124193 | $20.13 | 443,792.0000 | 95,130,053 | 38.86% | 0.13% |
| April 3, 2025 | Thompson Peter A. | Director | P | Common Stock | 372578 | $20.13 | 14,809,075.0000 | 95,130,053 | 2.58% | 0.39% |
| April 1, 2025 | Fox Jonathan C | Not found | A | Common Stock | 559 | $0.00 | 11,416.0000 | 95,130,053 | 5.15% | 0.00% |
| March 7, 2025 | KOCH KEVIN | President and CEO | M | Stock Option (Right to Buy) | 100 | $0.00 | 41,545.0000 | 92,414,626 | 0.24% | 0.00% |
| March 7, 2025 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 200 | $0.18 | 15,063.0000 | 92,414,626 | 1.35% | 0.00% |
| March 7, 2025 | KOCH KEVIN | President and CEO | S | Common Stock | 100 | $30.00 | 353,262.0000 | 92,414,626 | 0.03% | 0.00% |
| March 7, 2025 | KOCH KEVIN | President and CEO | M | Common Stock | 100 | $0.18 | 353,362.0000 | 92,414,626 | 0.03% | 0.00% |
| March 7, 2025 | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 200 | $0.00 | 1,456,580.0000 | 92,414,626 | 0.01% | 0.00% |
| March 7, 2025 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 200 | $30.02 | 14,863.0000 | 92,414,626 | 1.33% | 0.00% |
| Feb. 5, 2025 | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 8015 | $0.00 | 1,348,765.0000 | 92,414,626 | 0.59% | 0.01% |
| Feb. 6, 2025 | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 1200 | $0.00 | 1,347,565.0000 | 92,414,626 | 0.09% | 0.00% |
| Feb. 5, 2025 | KOCH KEVIN | President and CEO | M | Common Stock | 8636 | $0.18 | 361,898.0000 | 92,414,626 | 2.44% | 0.01% |
| Feb. 5, 2025 | KOCH KEVIN | President and CEO | S | Common Stock | 8636 | $30.03 | 353,262.0000 | 92,414,626 | 2.39% | 0.01% |
| Feb. 6, 2025 | KOCH KEVIN | President and CEO | M | Common Stock | 900 | $13.11 | 354,162.0000 | 92,414,626 | 0.25% | 0.00% |
| Feb. 6, 2025 | KOCH KEVIN | President and CEO | S | Common Stock | 900 | $31.13 | 353,262.0000 | 92,414,626 | 0.25% | 0.00% |
| Feb. 5, 2025 | KOCH KEVIN | President and CEO | M | Stock Option (Right to Buy) | 8636 | $0.00 | 42,545.0000 | 92,414,626 | 16.87% | 0.01% |
| Feb. 6, 2025 | KOCH KEVIN | President and CEO | M | Stock Option (Right to Buy) | 900 | $0.00 | 41,645.0000 | 92,414,626 | 2.12% | 0.00% |
| Feb. 5, 2025 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 10000 | $1.93 | 26,837.0000 | 92,414,626 | 59.39% | 0.01% |
| Feb. 5, 2025 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 10000 | $30.03 | 16,837.0000 | 92,414,626 | 37.26% | 0.01% |
| Feb. 5, 2025 | Derakhshan Behrad | Chief Business Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 92,929.0000 | 92,414,626 | 9.72% | 0.01% |
| Feb. 5, 2025 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 8015 | $0.18 | 22,878.0000 | 92,414,626 | 53.93% | 0.01% |
| Feb. 5, 2025 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 8015 | $30.02 | 14,863.0000 | 92,414,626 | 35.03% | 0.01% |
| Feb. 6, 2025 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 1200 | $0.18 | 16,063.0000 | 92,414,626 | 8.07% | 0.00% |
| Feb. 6, 2025 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1200 | $30.13 | 14,863.0000 | 92,414,626 | 7.47% | 0.00% |
| Jan. 28, 2025 | Donovan Joanne M. | CMO | S | Common Stock | 25000 | $27.63 | 16,358.0000 | 92,414,626 | 60.45% | 0.03% |
| Jan. 28, 2025 | Donovan Joanne M. | CMO | M | Common Stock | 25000 | $7.08 | 41,358.0000 | 92,414,626 | 152.83% | 0.03% |
| Jan. 28, 2025 | Donovan Joanne M. | CMO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 175,000.0000 | 92,414,626 | 12.50% | 0.03% |
| Jan. 21, 2025 | Blaustein Robert | Chief Development Officer | A | Stock Options (Right to buy) | 160000 | $0.00 | 160,000.0000 | 92,414,626 | 9999.99% | 0.17% |
| Jan. 21, 2025 | Blaustein Robert | Chief Development Officer | A | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 92,414,626 | 9999.99% | 0.03% |
| Dec. 30, 2024 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 100000 | $27.37 | 14,863.0000 | 93,813,346 | 87.06% | 0.11% |
| Dec. 30, 2024 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 100000 | $0.18 | 114,863.0000 | 93,813,346 | 672.81% | 0.11% |
| Dec. 30, 2024 | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 1,356,780.0000 | 93,813,346 | 6.86% | 0.11% |
| Dec. 24, 2024 | Semigran Marc | Chief Development Officer | M | Stock Option (Right to Buy) | 29709 | $0.00 | 270,291.0000 | 93,813,346 | 9.90% | 0.03% |
| Dec. 24, 2024 | Semigran Marc | Chief Development Officer | M | Common Stock | 29709 | $8.94 | 36,425.0000 | 93,813,346 | 442.36% | 0.03% |
| Dec. 24, 2024 | Semigran Marc | Chief Development Officer | S | Common Stock | 1729 | $30.08 | 6,716.0000 | 93,813,346 | 20.47% | 0.00% |
| Dec. 24, 2024 | Semigran Marc | Chief Development Officer | S | Common Stock | 27980 | $29.66 | 8,445.0000 | 93,813,346 | 76.82% | 0.03% |
| Oct. 11, 2024 | Carruthers R Michael | Chief Financial Officer | M | Common Stock | 70000 | $0.71 | 76,904.0000 | 93,813,346 | 1013.91% | 0.07% |
| Oct. 11, 2024 | Carruthers R Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 70000 | $0.00 | 127,122.0000 | 93,813,346 | 35.51% | 0.07% |
| Sept. 20, 2024 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 42068 | $1.93 | 57,189.0000 | 93,515,356 | 278.21% | 0.04% |
| Sept. 20, 2024 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 75000 | $0.18 | 87,719.0000 | 93,515,356 | 589.67% | 0.08% |
| Sept. 20, 2024 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 74185 | $28.25 | 13,534.0000 | 93,515,356 | 84.57% | 0.08% |
| Sept. 20, 2024 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 815 | $29.51 | 12,719.0000 | 93,515,356 | 6.02% | 0.00% |
| Sept. 20, 2024 | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 75000 | $0.00 | 1,456,780.0000 | 93,515,356 | 4.90% | 0.08% |
| Sept. 20, 2024 | MOORE JOHN R | General Counsel | M | Common Stock | 50000 | $0.71 | 53,252.0000 | 93,515,356 | 1537.52% | 0.05% |
| Sept. 20, 2024 | MOORE JOHN R | General Counsel | S | Common Stock | 50000 | $28.37 | 3,252.0000 | 93,515,356 | 93.89% | 0.05% |
| Sept. 23, 2024 | MOORE JOHN R | General Counsel | M | Common Stock | 20922 | $0.71 | 24,174.0000 | 93,515,356 | 643.36% | 0.02% |
| Sept. 23, 2024 | MOORE JOHN R | General Counsel | S | Common Stock | 20922 | $27.63 | 3,252.0000 | 93,515,356 | 86.55% | 0.02% |
| Sept. 20, 2024 | MOORE JOHN R | General Counsel | M | Stock Option (Right to Buy) | 50000 | $0.00 | 62,558.0000 | 93,515,356 | 44.42% | 0.05% |
| Sept. 23, 2024 | MOORE JOHN R | General Counsel | M | Stock Option (Right to Buy) | 20922 | $0.00 | 41,636.0000 | 93,515,356 | 33.44% | 0.02% |
| Sept. 20, 2024 | Donovan Joanne M. | CMO | S | Common Stock | 7162 | $28.29 | 14,538.0000 | 93,515,356 | 33.00% | 0.01% |
| Sept. 20, 2024 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 42068 | $29.03 | 15,121.0000 | 93,515,356 | 73.56% | 0.04% |
| Sept. 20, 2024 | Derakhshan Behrad | Chief Business Officer | M | Stock Option (Right to Buy) | 42068 | $0.00 | 102,949.0000 | 93,515,356 | 29.01% | 0.04% |
| Sept. 20, 2024 | Carruthers R Michael | Chief Financial Officer | M | Common Stock | 46068 | $1.93 | 81,996.0000 | 93,515,356 | 128.22% | 0.05% |
| Sept. 20, 2024 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 46068 | $28.59 | 35,928.0000 | 93,515,356 | 56.18% | 0.05% |
| Sept. 20, 2024 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 4064 | $28.59 | 31,864.0000 | 93,515,356 | 11.31% | 0.00% |
| Sept. 20, 2024 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 24960 | $28.59 | 6,904.0000 | 93,515,356 | 78.33% | 0.03% |
| Sept. 20, 2024 | Carruthers R Michael | Chief Financial Officer | M | Common Stock | 50000 | $1.93 | 56,904.0000 | 93,515,356 | 724.22% | 0.05% |
| Sept. 20, 2024 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 50000 | $28.55 | 6,904.0000 | 93,515,356 | 87.87% | 0.05% |
| Sept. 20, 2024 | Carruthers R Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 96068 | $0.00 | 40,990.0000 | 93,515,356 | 70.09% | 0.10% |
| Aug. 12, 2024 | Donovan Joanne M. | CMO | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Carruthers R Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| Aug. 12, 2024 | Carruthers R Michael | Chief Financial Officer | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Semigran Marc | Chief Development Officer | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| Aug. 12, 2024 | Semigran Marc | Chief Development Officer | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Russell Alan J | Chief Scientific Officer | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| Aug. 12, 2024 | Russell Alan J | Chief Scientific Officer | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | MOORE JOHN R | General Counsel | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| Aug. 12, 2024 | MOORE JOHN R | General Counsel | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Derakhshan Behrad | Chief Business Officer | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| Aug. 12, 2024 | Derakhshan Behrad | Chief Business Officer | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | KOCH KEVIN | President and CEO | A | Stock Option (Right to Buy) | 431250 | $0.00 | 431,250.0000 | 93,515,356 | 9999.99% | 0.46% |
| Aug. 12, 2024 | KOCH KEVIN | President and CEO | A | Restricted Stock Units | 71875 | $0.00 | 71,875.0000 | 93,515,356 | 9999.99% | 0.08% |
| Aug. 12, 2024 | Donovan Joanne M. | CMO | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| June 10, 2024 | Brege Laura | Not found | A | Stock Option (Right to Buy) | 20594 | $0.00 | 20,594.0000 | 87,567,307 | 9999.99% | 0.02% |
| June 10, 2024 | ROOT JONATHAN D | Not found | A | Stock Option (Right to Buy) | 20594 | $0.00 | 20,594.0000 | 87,567,307 | 9999.99% | 0.02% |
| June 10, 2024 | Edris Badreddin | Not found | A | Stock Option (Right to Buy) | 20594 | $0.00 | 20,594.0000 | 87,567,307 | 9999.99% | 0.02% |
| June 10, 2024 | Thompson Peter A. | Not found | A | Stock Options (Right to buy) | 20594 | $0.00 | 20,594.0000 | 87,567,307 | 9999.99% | 0.02% |
| June 10, 2024 | Fox Jonathan C | Not found | A | Stock Option (Right to Buy) | 20594 | $0.00 | 20,594.0000 | 87,567,307 | 9999.99% | 0.02% |
| June 10, 2024 | Morris Arlene | Not found | A | Stock Option (Right to Buy) | 20594 | $0.00 | 20,594.0000 | 87,567,307 | 9999.99% | 0.02% |
| May 6, 2024 | Morris Arlene | Not found | A | Stock Options (Right to buy) | 34311 | $0.00 | 34,311.0000 | 87,567,307 | 9999.99% | 0.04% |
| May 1, 2024 | MOORE JOHN R | General Counsel | M | Restricted Stock Units | 5208 | $0.00 | 5,209.0000 | 87,567,307 | 50.00% | 0.01% |
| May 2, 2024 | KOCH KEVIN | President and CEO | S | Common Stock | 3152 | $18.91 | 353,262.0000 | 87,567,307 | 0.88% | 0.00% |
| May 1, 2024 | KOCH KEVIN | President and CEO | M | Restricted Stock Units | 10417 | $0.00 | 10,417.0000 | 87,567,307 | 50.00% | 0.01% |
| May 1, 2024 | Donovan Joanne M. | CMO | M | Restricted Stock Units | 10417 | $0.00 | 10,417.0000 | 87,567,307 | 50.00% | 0.01% |
| May 2, 2024 | Donovan Joanne M. | CMO | S | Common Stock | 3682 | $18.91 | 19,897.0000 | 87,567,307 | 15.62% | 0.00% |
| May 1, 2024 | Donovan Joanne M. | CMO | M | Common Stock | 10417 | $0.00 | 23,579.0000 | 87,567,307 | 79.14% | 0.01% |
| May 1, 2024 | Russell Alan J | Chief Scientific Officer | M | Restricted Stock Units | 5208 | $0.00 | 5,209.0000 | 87,567,307 | 50.00% | 0.01% |
| May 2, 2024 | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1576 | $18.91 | 7,238.0000 | 87,567,307 | 17.88% | 0.00% |
| May 1, 2024 | Russell Alan J | Chief Scientific Officer | M | Common Stock | 5208 | $0.00 | 8,814.0000 | 87,567,307 | 144.43% | 0.01% |
| May 1, 2024 | Derakhshan Behrad | Chief Business Officer | M | Restricted Stock Units | 5208 | $0.00 | 5,209.0000 | 87,567,307 | 50.00% | 0.01% |
| May 2, 2024 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 1718 | $18.91 | 13,422.0000 | 87,567,307 | 11.35% | 0.00% |
| May 1, 2024 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 5208 | $0.00 | 15,140.0000 | 87,567,307 | 52.44% | 0.01% |
| May 1, 2024 | Carruthers R Michael | Chief Financial Officer | M | Restricted Stock Units | 5208 | $0.00 | 5,209.0000 | 87,567,307 | 50.00% | 0.01% |
| May 2, 2024 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 2157 | $18.91 | 35,230.0000 | 87,567,307 | 5.77% | 0.00% |
| May 1, 2024 | Carruthers R Michael | Chief Financial Officer | M | Common Stock | 5208 | $0.00 | 37,387.0000 | 87,567,307 | 16.18% | 0.01% |
| May 1, 2024 | KOCH KEVIN | President and CEO | M | Common Stock | 10417 | $0.00 | 356,414.0000 | 87,567,307 | 3.01% | 0.01% |
| May 2, 2024 | MOORE JOHN R | General Counsel | S | Common Stock | 1956 | $18.91 | 3,252.0000 | 87,567,307 | 37.56% | 0.00% |
| May 1, 2024 | MOORE JOHN R | General Counsel | M | Common Stock | 5208 | $0.00 | 5,208.0000 | 87,567,307 | 9999.99% | 0.01% |
| Feb. 8, 2024 | MOORE JOHN R | General Counsel | M | Common Stock | 3813 | $1.93 | 3,813.0000 | 63,723,600 | 9999.99% | 0.01% |
| Feb. 7, 2024 | MOORE JOHN R | General Counsel | M | Common Stock | 17993 | $1.93 | 17,993.0000 | 63,723,600 | 9999.99% | 0.03% |
| Feb. 7, 2024 | MOORE JOHN R | General Counsel | M | Stock Option (Right to Buy) | 17993 | $0.00 | 105,004.0000 | 63,723,600 | 14.63% | 0.03% |
| Feb. 9, 2024 | MOORE JOHN R | General Counsel | S | Common Stock | 8029 | $20.01 | 0.0000 | 63,723,600 | 100.00% | 0.01% |
| Feb. 9, 2024 | MOORE JOHN R | General Counsel | M | Common Stock | 8029 | $1.93 | 8,029.0000 | 63,723,600 | 9999.99% | 0.01% |
| Feb. 8, 2024 | MOORE JOHN R | General Counsel | S | Common Stock | 3813 | $20.01 | 0.0000 | 63,723,600 | 100.00% | 0.01% |
| Feb. 7, 2024 | MOORE JOHN R | General Counsel | S | Common Stock | 17993 | $20.00 | 0.0000 | 63,723,600 | 100.00% | 0.03% |
| Feb. 9, 2024 | Derakhshan Behrad | Chief Business Officer | M | Stock Option (Right to Buy) | 4800 | $0.00 | 145,017.0000 | 63,723,600 | 3.20% | 0.01% |
| Feb. 8, 2024 | Derakhshan Behrad | Chief Business Officer | M | Stock Option (Right to Buy) | 4600 | $0.00 | 149,817.0000 | 63,723,600 | 2.98% | 0.01% |
| Feb. 7, 2024 | Derakhshan Behrad | Chief Business Officer | M | Stock Option (Right to Buy) | 600 | $0.00 | 154,417.0000 | 63,723,600 | 0.39% | 0.00% |
| Feb. 9, 2024 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 4800 | $20.04 | 7,020.0000 | 63,723,600 | 40.61% | 0.01% |
| Feb. 9, 2024 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 4800 | $1.93 | 11,820.0000 | 63,723,600 | 68.38% | 0.01% |
| Feb. 8, 2024 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 4600 | $20.01 | 7,020.0000 | 63,723,600 | 39.59% | 0.01% |
| Feb. 8, 2024 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 4600 | $1.93 | 11,620.0000 | 63,723,600 | 65.53% | 0.01% |
| Feb. 7, 2024 | Derakhshan Behrad | Chief Business Officer | S | Common Stock | 600 | $20.00 | 7,020.0000 | 63,723,600 | 7.87% | 0.00% |
| Feb. 7, 2024 | Derakhshan Behrad | Chief Business Officer | M | Common Stock | 600 | $1.93 | 7,620.0000 | 63,723,600 | 8.55% | 0.00% |
| Feb. 9, 2024 | MOORE JOHN R | General Counsel | M | Stock Option (Right to Buy) | 8029 | $0.00 | 93,162.0000 | 63,723,600 | 7.93% | 0.01% |
| Feb. 8, 2024 | MOORE JOHN R | General Counsel | M | Stock Option (Right to Buy) | 3813 | $0.00 | 101,191.0000 | 63,723,600 | 3.63% | 0.01% |
| Jan. 23, 2024 | Carruthers R Michael | Chief Financial Officer | M | Stock Option (Right to Buy) | 90000 | $0.00 | 137,058.0000 | 63,723,600 | 39.64% | 0.14% |
| Jan. 23, 2024 | Carruthers R Michael | Chief Financial Officer | S | Common Stock | 90000 | $15.78 | 29,024.0000 | 63,723,600 | 75.62% | 0.14% |
| Jan. 23, 2024 | Carruthers R Michael | Chief Financial Officer | M | Common Stock | 90000 | $1.93 | 119,024.0000 | 63,723,600 | 310.09% | 0.14% |
| Jan. 23, 2024 | ORBIMED ADVISORS LLC | Director | P | Common Stock | 454545 | $11.00 | 14,756,096.0000 | 63,723,600 | 3.18% | 0.71% |
| Jan. 23, 2024 | Thompson Peter A. | Director | P | Common Stock | 454545 | $11.00 | 14,756,096.0000 | 63,723,600 | 3.18% | 0.71% |